Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131694) titled 'Clinical Phenotypes and Molecular Characteristics of Nephropathy Associated with Homozygous MYO1E Mutations' on Sept. 5.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Hereditary focal segmental glomerulosclerosis, steroid-resistant nephrotic syndrome
Intervention:
Case group:None
Healthy control group:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-09-15
Target Sample Size: Case group:1;Healthy control group:2;Tissue control group:2;
Countries of Recruitment:
China
To know more, visit htt...